The IRIS retinal hyperspectral imaging system from Photon etc. (Montreal, QC, Canada) delivers noninvasive localization of biomolecules in the eye fundus to develop treatments for retinal diseases such as diabetic retinopathy and age-related macular degeneration (AMD).

Lire l'article (version anglaise seulement)